Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Jul;71(7):914–924. doi: 10.1002/acr.23837

Table 2.

Hazard ratios for rheumatoid arthritis serologic phenotypes by smoking status and intensity.


Never Past Current, 1–14 cigarettes/day Current, 15–24 cigarettes/day Current, ≥25 cigarettes/day
HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI)

All RA
Cases/person-years 675/3,262,927 597/1,946,910 80/316,907 111/330,369 65/180,038
Age-adjusted model 1.00 (Ref) 1.35(1.20,1.51) 1.19(0.94,1.50) 1.58(1.28,1.94) 1.69(1.30,2.19)
Multivariable model* 1.00 (Ref) 1.36(1.21,1.53) 1.23(0.97,1.55) 1.60(1.30,1.97) 1.69(1.30,2.20)

Seropositive RA
Cases/person-years 415/3,254,327 386/1,940,936 52/315,778 73/329,167 43/179,214
Age-adjusted model 1.00 (Ref) 1.44(1.25,1.66) 1.29(0.97,1.73) 1.75(1.35,2.25) 1.86(1.35,2.58)
Multivariable model* 1.00 (Ref) 1.48(1.28,1.71) 1.36(1.01,1.82) 1.80(1.39,2.34) 1.92(1.39,2.66)

Seronegative RA
Cases/person-years 260/3,254,901 211/1,940,814 28/315,756 38/328,645 22/178,974
Age-adjusted model 1.00 (Ref) 1.20(1.00,1.44) 1.03(0.70,1.53) 1.32(0.94,1.88) 1.42(0.91,2.21)
Multivariable model* 1.00 (Ref) 1.18(0.98,1.43) 1.03(0.69,1.53) 1.31(0.92,1.86) 1.36(0.86,2.12)
*

Multivariable models were adjusted for age, questionnaire period, cohort, oral contraceptive use (ever, never), parity/breastfeeding in months (nulliparous, parous/<1 month, parous/1–11 months, parous/≥12 months), menopausal status/postmenopausal hormone use (premenopausal, postmenopausal/never, postmenopausal/ever), body mass index category (underweight/normal, overweight, obese), sedentary physical activity, median household income (quartiles), alcohol intake (none/<5 g/day, 5 to <10 g/day, ≥10 g/day).